Author:
Davies G C,Sobel M,Salzman E W
Abstract
Patients who underwent operations in which cardiopulmonary bypass was used had elevations of plasma fibrinopeptide A which did not return to normal during bypass despite conventional heparin anticoagulation, suggesting inadequate heparin dosage and continued thrombin activity during the operation. Patients who underwent aortocoronary artery grafting had high plasma thromboxane B2 levels and a rapid fall in platelet count at the onset of extracorporeal circulation. Thromboxane elevations were less marked in patients who underwent valve replacement. Platelet aggregation and coronary artery constriction secondary to thromboxane production may contribute to the morbidity of cardiopulmonary bypass.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference30 articles.
1. Berger S Salzman EW: Thromboembolic complications of prosthetic devices. In Progress in Hemostasis and Thrombosis vol 11 edited by Spaet T. New York Grune and Stratton 1974 p 273
2. Blomback B: Fibrinogen to fibrin transformation. In Blood Clotting Enzymology edited by Seegers WH. New York Academic Press Inc 1967 p 143
3. Potential Use of Fibrinopeptide A Measurements in the Diagnosis and Management of Thrombosis
4. Bayley T Clements J Osbahr A: Pulmonary and circulatory effects of fibrinopeptides. Circ Res 21. 469 1967
5. On the capillary permeability enhancing activity of isolated fibrinopeptides and their role in the physiology of the blood capillary wall;Copley AL;Bibl Anat,1967
Cited by
180 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献